Abstract:The present work systematically gives a comprehensive review in current developments of benzimidazole–oxadiazole hybrid compounds in the whole range of medicinal chemistry and the perspectives that they hold for future research. To increase the success rate of drug discovery, one practical strategy is to begin molecular hybridisation. The presence of two or more pharmacophores in a single unit leads to a pharmacological potency greater than the sum of each individual moiety's potency. Heterocyclic compounds are very widely distributed in nature and are essential for life activities. Benzimidazole and oxadiazole are privileged structures in medicinal chemistry and are widely used in drug discovery and development due to their vast biological properties. The drug‐like properties (like pharmacokinetics and pharmacodynamics) of the individual scaffolds can be improved by benzimidazole–oxadiazole chimeric molecules via a molecular hybridisation approach. Benzimidazole and oxadiazole cores can either be fused or incorporated using either functional groups/bonds. Over the last few decades, drug discovery scientists have predicted that these moieties could be interconnected to yield a novel or modified hybrid compound. Benzimidazole and oxadiazole hybrids were identified as the most potent anticancer, antimicrobial, anti‐inflammatory, antioxidant, anticonvulsant, antidepressant, antihypertensive and antitubercular agents. In this context, the present review describes the biological properties of benzimidazole–oxadiazole (1,3,4 and 1,2,4) hybrids, their possible structure–activity relationship and the mechanism of action studies presented. This review article is intended to stimulate fresh ideas in the search for rational designs of more active and less toxic benzimidazole–oxadiazole hybrid prospective therapeutic candidates, as well as more effective diagnostic agents and pathologic probes.

To homeostasis and beyond! Recent advances in the medicinal chemistry of heterobifunctional derivatives

Bifunctional modalities for repurposing protein function

Designing Chimeric Molecules for Drug Discovery by Leveraging Chemical Biology

Proximity-Based Modalities for Biology and Medicine

Bisindolylmethanes and Relative Compounds: Synthesis, Green Chemistry, Drug Discovery and Environmental Pollution Control

Intramolecular hydrogen bonding: An opportunity for improved design in medicinal chemistry

Mutual leveraging of proximity effects and click chemistry in chemical biology

Recent developments on the synthesis of biologically active glycohybrids

Development of drugs based on imidazole and benzimidazole bioactive heterocycles: recent advances and future directions

Indole Derivatives: A Versatile Scaffold in Modern Drug Discovery—An Updated Review on Their Multifaceted Therapeutic Applications (2020–2024)

Development in the Synthesis of Bioactive Thiazole-Based Heterocyclic Hybrids Utilizing Phenacyl Bromide

Metabolism of new drug modalities research advances - 2023 year in review

Application of covalent modality in proximity-induced drug pharmacology: Early development, current strategy, and feature directions

Late-stage modification of bioactive compounds: Improving druggability through efficient molecular editing

Beyond Proteolysis-Targeting Chimeric Molecules: Designing Heterobifunctional Molecules Based on Functional Effectors

Prodrug Rewards in Medicinal Chemistry: An Advance and Challenges Approach for Drug Designing

A medicinal chemistry perspective of drug repositioning: Recent advances and challenges in drug discovery

Benzimidazole: A Versatile Scaffold for Drug Discovery and Beyond - A Comprehensive Review of Synthetic Approaches and Recent Advancements in Medicinal Chemistry

Benzimidazole–Oxadiazole Hybrids—Development in Medicinal Chemistry: An Overview

Emerging TACnology: Heterobifunctional Small Molecule Inducers of Targeted Posttranslational Protein Modifications

Chemically induced proximity in biology and medicine